Advances in Sepsis -an independent journal published by Remedica Medical Education and Publishing Ltd. . The aim is to provide an up-to-date overview of the recent literature compiled by an international team of practicing physicians. Leading articles commissioned by the Editors-in-Chief review new therapeutic techniques and emerging technologies, and news from major international meetings is reported. Editorial control is vested entirely in the Editor-in-Chief and Editorial Board. Any queries regarding the content of the journal should be addressed to:

The material published in Advances in Sepsis is FREE from copyright restriction when used for non-commercial educational purposes. For example, we will be happy to provide content for educational web sites - either in the form of a simple web link, or as content for the web pages themselves. We can also provide material for teaching activities or for local societies - PDFs of articles or sections from the journal are available, again for no charge, either for you to print and duplicate or to post on the web. Please fill in the details below to let us know what you would like to use, and for what purpose, and we will be in touch.
I would like to request:
I want to use this for:
Name:
Organization:
Speciality:
E-mail address:
Telephone:

In this month's SMART: Crucial Presentations from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Research and treatment in pediatric sepsis. Key papers and news from the world media.
Enter SMART >>

Activate your personal SMARTbot today! You choose how SMARTbot will search PubMed. SMARTbot will report back (you decide how often) with the results from your customised searches
Activate your personal SMARTbot today! >>

The material published in Advances in Sepsis is FREE from copyright restriction when used for non-commercial educational purposes.
More information

Advances in Sepsis, SMART™, and SMARTbot™ are supported by educational grants from Eli Lilly and Company, Acute Care. Certain authors and editors may have financial or other relationships with Eli Lilly and Company. Some of the information/data reported here for drugs/devices discussed may differ from information/data contained in the prescribing information approved by regulatory authorities in specific countries. For approved information and uses for drugs/devices discussed, please consult the manufacturer's prescribing information.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of ACCME through the joint sponsorship of the University of Kentucky College of Medicine and Remedica. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Kentucky is an equal opportunity university.